Search EDI

Latest Stories

 

 

 

By Industry

MRO



MBA Member

Enter your Email


Preview | Powered by FeedBlitz
EDI Resources
Featured Sections

« Stratolaunch to enable safer, less expensive space flight | Main | Nissan makes LEAF reservations available to Canadians »
Monday
Dec122011

MaRS to provide support for 5 emerging businesses

MaRS is to support five Ontario businesses through the Investment Accelerator Fund (IAF), a program that provides an equity-type investment to businesses that develop and bring to market innovative new technologies or services.

The following businesses will receive support from the IAF:

  • Verold, a software company whose content creation platform significantly reduces the time required to create ready-to-animate 3D content for media consumption (games, web content and AR/VR worlds).
  • FuturestateIT, a company whose SaaS solution called AppRx  automates the monitoring and testing of applications to ensure they are kept current, compatible and compliant with changes in the IT environment.
  • SurfEasy, for their USB key that improves Internet privacy and security through password protection and encryption. The USB key securely stores the user's web history, bookmarks and passwords, ensuring no personal data is left behind on the computer or network.
  • GreenMantra, which uses a proprietary catalyst to economically produce commercial quality waxes and fuels by recycling plastics. The company's pilot facility is now consistently producing waxes that have been evaluated by over 20 potential customers.

 

The Investment Accelerator Fund-Life Sciences (IAF-LS) supports the launch and development of innovative companies in Ontario's priority sectors: advanced materials and manufacturing, information technology, cleantech and life sciences. The fund has committed to providing an equity-type investment in the following business:

 

  • Interface Biologics Inc. (IBI), a privately held, early-stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. The company focuses on 1) anti-thrombogenic additives that reduce thrombosis without the need for heparin and 2) programmable combination drug delivery devices.

 

MaRS Discovery District (www.marsdd.com) is a mission-driven innovation centre located in Toronto. MaRS works with partners to catalyze, accelerate and amplify innovation. MaRS supports entrepreneurs building Canada's next generation of growth companies.

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>